The burden of prostate cancer is associated with human development index: evidence from 87 countries, 1990-2016.

作者： Rajesh Sharma

关键词:

摘要: To examine the temporal patterns of prostate cancer burden and its association with human development. The estimates incidence mortality for 87 countries were obtained from Global Burden Disease 2016 study period 1990 to 2016. development level a country was measured using index (HDI): summary indicator health, education, income. between (HDI) pairwise correlation bivariate regression. Mortality-to-incidence ratio (MIR) employed as proxy survival rate cancer. Globally, 1.4 million new cases arose in claiming 380,916 lives which more than doubled 579,457 incident 191,687 deaths 1990. In 2016, age-standardised (ASIR) highest very high–HDI led by Australia ASIR 174.1/100,000 showed strong positive HDI (r = 0.66); (ASMR), however, higher low-HDI Zimbabwe ASMR 78.2/100,000 MIR decreased 0.33 0.26 exhibited negative gradient (r = − 0.91) tenfold variation globally seven recording excess 1 USA minimum 0.10. high lower rates less-developed demand all-inclusive solutions ranging cost-effective early screening detection treatment. tackling rising predictive, preventive personalised medicine (PPPM) can play useful role through prevention strategies, predicting PCa precisely accurately multiomic approach risk-stratifying patients provide medicine.

参考文章(40)

, David C. Grossman, Susan J. Curry, Douglas K. Owens, Kirsten Bibbins-Domingo, Aaron B. Caughey, Karina W. Davidson, Chyke A. Doubeni, Mark Ebell, John W. Epling, Alex R. Kemper, Alex H. Krist, Martha Kubik, C. Seth Landefeld, Carol M. Mangione, Michael Silverstein, Melissa A. Simon, Albert L. Siu, Chien-Wen Tseng, Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. ,vol. 319, pp. 1901- 1913 ,(2018) , 10.1001/JAMA.2018.3710

Deborah Carvalho Malta, Lorenzo G. Mantovani, Brian J. McMahon, Toni Meier, Yohannes Adama Melaku, Mulugeta Melku, Peter Memiah, Walter Mendoza, Tuomo J. Meretoja, Haftay Berhane Mezgebe, Ted R. Miller, Shafiu Mohammed, Ali H. Mokdad, Mahmood Moosazadeh, Paula Moraga, Seyyed Meysam Mousavi, Vinay Nangia, Cuong Tat Nguyen, Vuong Minh Nong, Felix Akpojene Ogbo, Andrew Toyin Olagunju, Mahesh PA, Eun-Kee Park, Tejas Patel, David M. Pereira, Farhad Pishgar, Maarten J Postma, Farshad Pourmalek, Mostafa Qorbani, Anwar Rafay, Salman Rawaf, David Laith Rawaf, Gholamreza Roshandel, Saeid Safiri, Hamideh Salimzadeh, Juan Ramon Sanabria, Milena M. Santric Milicevic, Benn Sartorius, Maheswar Satpathy, Sadaf G. Sepanlou, Katya Anne Shackelford, Masood Ali Shaikh, Mahdi Sharif-Alhoseini, Jun She, Min-Jeong Shin, Ivy Shiue, Mark G. Shrime, Abiy Hiruye Sinke, Mekonnen Sisay, Amber Sligar, Muawiyyah Babale Sufiyan, Bryan L. Sykes, Rafael Tabarés-Seisdedos, Gizachew Assefa Tessema, Roman Topor-Madry, Tung Thanh Tran, Bach Xuan Tran, Kingsley Nnanna Ukwaja, Vasiliy Victorovich Vlassov, Stein Emil Vollset, Elisabete Weiderpass, Hywel C. Williams, Nigus Bililign Yimer, Naohiro Yonemoto, Mustafa Z. Younis, Christopher J. L. Murray, Mohsen Naghavi, , Christina Fitzmaurice, Tomi F. Akinyemiju, Faris Hasan Al Lami, Tahiya Alam, Reza Alizadeh-Navaei, Christine Allen, Ubai Alsharif, Nelson Alvis-Guzman, Erfan Amini, Benjamin O. Anderson, Olatunde Aremu, Al Artaman, Solomon Weldegebreal Asgedom, Reza Assadi, Tesfay Mehari Atey, Leticia Avila-Burgos, Ashish Awasthi, Huda Omer Ba Saleem, Aleksandra Barac, James R. Bennett, Isabela M. Bensenor, Nickhill Bhakta, Hermann Brenner, Lucero Cahuana-Hurtado, Carlos A. Castañeda-Orjuela, Ferrán Catalá-López, Jee-Young Jasmine Choi, Devasahayam Jesudas Christopher, Sheng-Chia Chung, Maria Paula Curado, Lalit Dandona, Rakhi Dandona, José das Neves, Subhojit Dey, Samath D. Dharmaratne, David Teye Doku, Tim R. Driscoll, Manisha Dubey, Hedyeh Ebrahimi, Dumessa Edessa, Ziad El-Khatib, Aman Yesuf Endries, Florian Fischer, Lisa M. Force, Kyle J. Foreman, Solomon Weldemariam Gebrehiwot, Sameer Vali Gopalani, Giuseppe Grosso, Rahul Gupta, Bishal Gyawali, Randah Ribhi Hamadeh, Samer Hamidi, James Harvey, Hamid Yimam Hassen, Roderick J. Hay, Simon I. Hay, Behzad Heibati, Molla Kahssay Hiluf, Nobuyuki Horita, H. Dean Hosgood, Olayinka S. Ilesanmi, Kaire Innos, Farhad Islami, Mihajlo B. Jakovljevic, Sarah Charlotte Johnson, Jost B. Jonas, Amir Kasaeian, Tesfaye Dessale Kassa, Yousef Saleh Khader, Ejaz Ahmad Khan, Gulfaraz Khan, Young-Ho Khang, Mohammad Hossein Khosravi, Jagdish Khubchandani, Jacek A. Kopec, G. Anil Kumar, Michael Kutz, Deepesh Pravinkumar Lad, Alessandra Lafranconi, Qing Lan, Yirga Legesse, James Leigh, Shai Linn, Raimundas Lunevicius, Azeem Majeed, Reza Malekzadeh, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration JAMA Oncology. ,vol. 4, pp. 1553- 1568 ,(2018) , 10.1001/JAMAONCOL.2018.2706

James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Gary MacVicar, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach, Eric Rohren, Bruce J. Roth, Dennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C. Walsh, Prostate cancer. Clinical practice guidelines in oncology. Journal of The National Comprehensive Cancer Network. ,vol. 8, pp. 162- 200 ,(2010) , 10.6004/JNCCN.2010.0012

Chin-Lee Wu, Ya-Qiang Huang, Wei-De Zhong, Tong Sun, Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer. American journal of clinical and experimental urology. ,vol. 2, pp. 343- 350 ,(2014)

M. Quinn, P. Babb, Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries. BJUI. ,vol. 90, pp. 174- 184 ,(2002) , 10.1046/J.1464-410X.2002.02823.X

Richard P Horgan, Louise C Kenny, ‘Omic’ technologies: genomics, transcriptomics, proteomics and metabolomics The Obstetrician and Gynaecologist. ,vol. 13, pp. 189- 195 ,(2011) , 10.1576/TOAG.13.3.189.27672

Vasu Sunkara, James R. Hébert, The colorectal cancer mortality‐to‐incidence ratio as an indicator of global cancer screening and care Cancer. ,vol. 121, pp. 1563- 1569 ,(2015) , 10.1002/CNCR.29228

Scott A. Tomlins, John R. Day, Robert J. Lonigro, Daniel H. Hovelson, Javed Siddiqui, L. Priya Kunju, Rodney L. Dunn, Sarah Meyer, Petrea Hodge, Jack Groskopf, John T. Wei, Arul M. Chinnaiyan, Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment European Urology. ,vol. 70, pp. 45- 53 ,(2016) , 10.1016/J.EURURO.2015.04.039

Stacy Loeb, Martin G. Sanda, Dennis L. Broyles, Sanghyuk S. Shin, Chris H. Bangma, John T. Wei, Alan W. Partin, George G. Klee, Kevin M. Slawin, Leonard S. Marks, Ron H.N. van Schaik, Daniel W. Chan, Lori J. Sokoll, Amabelle B. Cruz, Isaac A. Mizrahi, William J. Catalona, The prostate health index selectively identifies clinically significant prostate cancer The Journal of Urology. ,vol. 193, pp. 1163- 1169 ,(2015) , 10.1016/J.JURO.2014.10.121

10.

Monique J Roobol, Ries Kranse, Chris H Bangma, Arno GJLH van Leenders, Bert G Blijenberg, Ron HN van Schaik, Wim J Kirkels, Suzie J Otto, Theo H van der Kwast, Harry J de Koning, Fritz H Schröder, ERSPC Rotterdam Study Group, Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer European Urology. ,vol. 64, pp. 530- 539 ,(2013) , 10.1016/J.EURURO.2013.05.030

The burden of prostate cancer is associated with human development index: evidence from 87 countries, 1990-2016.

来源期刊

我的账户

The burden of prostate cancer is associated with human development index: evidence from 87 countries, 1990-2016.

来源期刊

相似文章 8

我的账户